Xencor (XNCR) Change in Accured Expenses (2013 - 2026)

Xencor (XNCR) reported Change in Accured Expenses of -$707000.0 for Q1 2026, up 77.58% year-over-year from -$398121.4 in Q1 2025, and down 110.18% quarter-over-quarter from $6.9 million in Q4 2025.

Xencor (XNCR) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Change in Accured Expenses data on file, last reported at -$707000.0 in Q1 2026.

  • Change in Accured Expenses for Q1 2026 came in at -$707000.0, up 77.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.2 million (up 531.53% YoY), and the FY2025 annual result was $13.8 million, up 417.37% from the prior year.
  • Change in Accured Expenses fell to -$707000.0 in Q1 2026 per XNCR's latest filing, from $6.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $6.9 million in Q4 2025 and troughed at -$10.1 million in Q1 2024.
  • A 5-year average of $756647.1 and a median of $2.9 million in 2022 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 581.72% in 2024, then jumped 212.15% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$561000.0 in 2022, then slumped by 61.85% to -$908000.0 in 2023, then plunged by 581.72% to -$6.2 million in 2024, then jumped by 212.15% to $6.9 million in 2025, then slumped by 110.18% to -$707000.0 in 2026.
  • Business Quant data shows XNCR's Change in Accured Expenses at -$707000.0 in Q1 2026, $6.9 million in Q4 2025, and $4.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -707,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -707,000.00
Mar 31, 2026 -707,000.00
Dec 31, 2025 6.94 Mn
Dec 31, 2025 6.94 Mn
Sep 30, 2025 4.22 Mn
Sep 30, 2025 4.22 Mn
Jun 30, 2025 5.79 Mn
Jun 30, 2025 5.79 Mn
Mar 31, 2025 -3.15 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 -6.19 Mn
Dec 31, 2024 -6.19 Mn
Sep 30, 2024 5.85 Mn
Sep 30, 2024 5.85 Mn
Jun 30, 2024 6.07 Mn
Jun 30, 2024 6.07 Mn
Mar 31, 2024 -10.07 Mn
Mar 31, 2024 -10.07 Mn
Dec 31, 2023 -908,000.00
Dec 31, 2023 -908,000.00